The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the mcao model of focal ischemia in the rat

Experimental Neurology

Volumn 145, Issue 2 I, 1997, Pages 425-433

  Bordi, Fabio ^a   Pietra, Claudio ^a   Ziviani, Luigi ^a   Reggiani, Angelo ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAVESTINEL; GLYCINE RECEPTOR ANTAGONIST; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN REGION; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EVOKED SOMATOSENSORY RESPONSE; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SOMATOSENSORY CORTEX;

EID: 0030739272     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6442     Document Type: Article

References (26)

1. Allison, T., and A. L. Hume. 1981. A comparative analysis of short-latency somatosensory evoked potentials in man, monkey, cat, and rat. Exp. Neurol. 72: 592-611.
2. Anziska, B. J., and R. Q. Cracco. 1981. Short latency SEPs to median nerve stimulation: Comparison of recording methods and origin of components. EEG Clin. Neurophys. 52: 531-539.
3. Bartus, R. T., R. L. Dean, K. Cavanaugh, D. Eveleth, D. L. Carriero, and G. Lynch. 1995. Time-related neuronal changes following middle cerebral artery occlusion: Implications for therapeutic intervention and the role of calpain. J. Cereb. Blood Flow Metab. 15: 969-979.
4. Bederson, J. B., L. H. Pitts, M. Tsuji, M. C. Nishimura, R. L. Davis, and H. Bartkowski. 1986. Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke 17: 472-477.
5. Bielenberg, G. W. and T. Beck. 1991. The effect of dizocilpine (MK-801), phencyclidine, and nimodipine on the infarct size 48 hr after middle cerebral artery occlusion in the rat. Brain Res. 552: 338-342.
6. Bordi, F. and J. E. LeDoux. 1994. Response properties of single units in areas of rat auditory thalamus that project to the amygdala. II. Cells receiving convergent auditory and somatosensory inputs and cells antidromically activated by amygdala stimulation. Exp. Brain Res. 98: 275-286.
7. Branston, N. M., L. Symon, and H. A. Crockard. 1974. Relationship between the cortically evoked potential and local cortical blood flow following acute middle cerebral artery occlusion in the baboon. Exp. Neurol. 45: 195-208.
8. Bunegin, L., M. S. Albin, and P. Hesel. 1981. Cerebral blood flow and the evoked response. J. Cereb. Blood Flow Metab. 1: S226-S227.
9. Chiamulera, C., S. Costa, and A. Reggiani. 1991. Effect of NMDA- and strychnine-insensitive glycine antagonists on NMDA-mediated convulsions and learning. Psychopharmacology 102: 551-552.
10. Choi, D. W. 1990. Methods for antagonizing glutamate neurotoxicity. Cerebrovasc. Brain Metab. Rev. 2: 105-147.
11. Di Fabio, R., et al. 1997. Substituted indole-2-carboxylates as in vivo potent antagonists acting at the strychnine-insensitive glycine binding site. Submitted for publication.
12. Graham, S. H., J. Chen, F. R. Sharp, and P. R. Simon. 1993. Limiting ischemic injury by inhibition of excitatory amino acid release. J. Cereb. Blood Flow Metab. 13: 88-97.
13. Hargreaves, R., M. Rigby, D. Sith, and R. G. Hill. 1993. Lack of effect of L-678,414 ((+)cis-4-mirthyl HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology. Br. J. Pharmacol. 110: 36-42.
14. Kato, T., Y. Maruoka, A. Kawabe, C. Kawasima, K. Ohtani, and M. Nakamura. 1995. Neuroprotective and anticonvulsant actions of SM18400, a novel strichnine-insensitive glycine site antagonist. J. Cereb. Blood Flow Metab. 15: S431.
15. Lye, R. H., J. Shrewsbury-Gee, P. Slater, and A. Latham. 1987. Rat middle cerebral artery occlusion: Use of evoked potentials and tetrazolium staining to assess chronic ischemia. J. Neurosci. Methods 25: 153-159.
16. Markgraf, C. G., E. J. Green, B. E. Hurwitz, E. Morikawa, W. D. Dietrich, P. M. McCabe, M. D. Ginsberg, and N. Schneiderman. 1992. Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats. Brain Res. 575: 238-246.
17. McLaughlin, D. F. and E. F. Kelly. 1993. Evoked potentials as indices of adaptation in the somatosensory system in humans: A review and prospectus. Brain Res. Rev. 18: 151-206.
18. Park, C. K., D. G. Nehls, D. I. Graham, G. M. Teasdale, and J. Mc Culloch. 1988. The glutamate antagonist MK-801 reduced focal ischemic brain damage in the rat. Ann. Neurol. 24: 543-551.
19. Paxinos, G., and C. Watson. 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney, Australia.
20. Ratti, E., M. Corsi, C. Carignani, A. Cugola, M. Mugnaini, G. Gaviraghi, D. G. Trist, and A. Reggiani. 1995. Pharmacological characterization of the novel glycine antagonist GV150526: In vitro studies. Eur. J. Neurol. 2: 57-58. (a) Seidler. 1980.
21. Bederson, J. B., L. H. Pitts, S. M. Germans, M. C. Nishimura, R. L. Davis, and H. M. Bartkowski. 1986. Evaluation of 2, 3, 5-triphenyltetrazolium chloride as a strain for detection and quantification of experimental cerebral infarction in rats. Stroke 17: 1304-1308.
22. Shaw, N. A. 1986. Somatosensory evoked potentials after experimental head injury in the awake rat. J. Neurol. Sci. 74: 257-270.
23. Simon, R. P., J. H. Swan, T. Griffith, and B. S. Meldrum. 1984. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226: 850-852.
24. Tamura, A., D. I. Graham, J. McCulloch, and G. M. Teasdale. 1981. Focal cerebral ischemia in the rat: I. Description of technique and early neuropathological consequences following middle artery occlusion. J. Cereb. Blood Flow Metab. 1: 53-60.
25. Wahlestedt, C., E. Golanov, S. Yamamoto, F. H. E. Yee, H. Yoo, C. E. Inturrisi, and D. J. Reis. 1993. Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduces focal ischemic infarctions. Nature 363: 360-363.
26. Warner, D. S., H. Martin, P. Ludwig, A. McAllister, J. F. W. Keana, and E. Weber. 1995. In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists. J. Cereb. Blood Flow Metab. 15: 188-196.